Eledon Pharmaceuticals (ELDN) Change in Acquisitions & Divestments (2016 - 2026)

Eledon Pharmaceuticals (ELDN) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $49.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 37.31% year-over-year to $49.1 million; the trailing twelve-month figure through Mar 2026 stood at $185.3 million (up 87.4% YoY), and the FY2025 full-year result was $171.9 million, up 100.34% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $49.1 million, up from $48.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $49.1 million in Q1 2026 and bottomed at $16.4 million in Q2 2024.
• The 4-year median for Change in Acquisitions & Divestments is $31.9 million (2023), against an average of $33.5 million.
• The widest annual swing landed in 2024, when Change in Acquisitions & Divestments declined 9.29%; it then surged 158.3% in 2025.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $28.0 million in 2023, then slipped by 9.29% to $25.4 million in 2024, then surged by 91.98% to $48.8 million in 2025, then rose by 0.65% to $49.1 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $49.1 million (Q1 2026), $48.8 million (Q4 2025), and $45.1 million (Q3 2025), per Business Quant data.

Peer Comparison